Pyk2 promotes tumor progression in multiple myeloma. [electronic resource]
Producer: 20150126Description: 2675-86 p. digitalISSN:- 1528-0020
- Aminopyridines -- pharmacology
- Animals
- Cell Adhesion -- drug effects
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cells, Cultured
- Disease Progression
- Female
- Focal Adhesion Kinase 2 -- antagonists & inhibitors
- Gene Expression Regulation, Enzymologic -- drug effects
- Green Fluorescent Proteins -- genetics
- HEK293 Cells
- Humans
- Immunoblotting
- Luminescent Measurements
- Mice, SCID
- Multiple Myeloma -- genetics
- Protein Kinase Inhibitors -- pharmacology
- RNA Interference
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Analysis
- Tumor Burden -- drug effects
- Wnt Signaling Pathway -- drug effects
- Xenograft Model Antitumor Assays
- beta Catenin -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.